Walking in Pregnancy and Prevention of Insomnia in Third Trimester Using Pedometers

NCT ID: NCT03735381

Last Updated: 2019-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

265 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-02

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized Control Trial (RCT), were healthy but sedentary women are selected in their first trimester of pregnancy. This RCT has two interventions arms (pedometer plus a goal of 11,000 steps / day and pedometer without goal) and a control group arm, without the use of pedometer. The main objective is to promote physical activity in pregnancy decreasing the prevalence of insomina at their third trimester of pregnancy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

General Objective: To determine the effect of a walking program during pregnancy in the prevention of the appearance of insomnia in the third trimester of pregnancy, in the increase of the quality of sleep and in the improvement of the quality of life throughout pregnancy.

Specific Objectives: Comparison of the interventions group versus the control group; at the beginning, middle and end of the program of the following indicators: 1. Average steps/day; 2. Frequency of insomnia; 3. Hours of night sleep and quality of sleep; 4. Quality of life level.

Methodology: Randomized Control trial in parallel in healthy sedentary pregnant women belonging to the Virgen de las Nieves Hospital in Granada, Spain. At 12 weeks of gestation (GW) they will be invited to participate and randomly assigned to the intervention group I2 (pedometer, with goal of 11,000 steps / day), intervention group I1 (pedometer without goal) and control (without pedometer). Duration of the intervention: 13-32 GW. At 12, 19 and 31GW the average steps/day will be measured in groups I2 and I1. In weeks 13, 20 and 32GW, the following variables will be collected: the Athens Insomnia Scale, the Sleep Quality Index (Pittsburgh), adherence to the Mediterranean Diet (Predimed), physical activity (short IPAQ), quality of life (PSI), the consumption of toxic substances (caffeine, illegal drugs, alcohol and tobacco), the anthropometric variables of pregnant woman.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insomnia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
Participants know they will be selected for either a pedometer group or a not pedometer group. They wil not know if the intervention is minimum (pedometer only) or maximum (pedometer and a goal of 11000 steps/day)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention 1: pedometer

Minimum intervention:

1. Use of pedometer watch from 12 to 32 GW
2. Recommendations of physical activity

Group Type ACTIVE_COMPARATOR

Pedometer watch 'Xiomi mi band2'

Intervention Type DEVICE

1. They receive information on the use of the pedometer.
2. Carry the pedometer (Xiaomi Mi Band 2 ™) from 12 to 32GW.
3. Prescription of benefits of walking in pregnancy:

* Receive information about the goal of steps / day to be reached: 10,000-11,000 steps / day (Only the intervention 2 group).
* Receive information on the adequacy of walking with moderate intensity.
4. They will receive messages on the mobile phone remembering the goal to achieve and a notification that the researching staff will proceed to collect the average count of steps / day of the week prior to 20 and 32 gestation weeks (only for the intervention 2 group).

Intervention 2: pedometer+goal+reminds

Maximum intervention:

1. Use of pedometer from 12 to 32 GW
2. Recommendations of physical activity
3. Information about get a goal of 11000 steps/day
4. Reminds the goal every two weeks.

Group Type EXPERIMENTAL

Pedometer watch 'Xiomi mi band2'

Intervention Type DEVICE

1. They receive information on the use of the pedometer.
2. Carry the pedometer (Xiaomi Mi Band 2 ™) from 12 to 32GW.
3. Prescription of benefits of walking in pregnancy:

* Receive information about the goal of steps / day to be reached: 10,000-11,000 steps / day (Only the intervention 2 group).
* Receive information on the adequacy of walking with moderate intensity.
4. They will receive messages on the mobile phone remembering the goal to achieve and a notification that the researching staff will proceed to collect the average count of steps / day of the week prior to 20 and 32 gestation weeks (only for the intervention 2 group).

Control: without pedometer

Women receive some recommendations of physical activity during pregnancy. They do not use the pedometer during pregnancy

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pedometer watch 'Xiomi mi band2'

1. They receive information on the use of the pedometer.
2. Carry the pedometer (Xiaomi Mi Band 2 ™) from 12 to 32GW.
3. Prescription of benefits of walking in pregnancy:

* Receive information about the goal of steps / day to be reached: 10,000-11,000 steps / day (Only the intervention 2 group).
* Receive information on the adequacy of walking with moderate intensity.
4. They will receive messages on the mobile phone remembering the goal to achieve and a notification that the researching staff will proceed to collect the average count of steps / day of the week prior to 20 and 32 gestation weeks (only for the intervention 2 group).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Low risk pregnancies that are attending in the Unit of Obstetrics and Gynecology of the Hospital Materno-Infantil de Granada.
* Sedentary women (\<5 days/week of moderate-vigorous physical activity at least \>30 min.; equivalent to \<7.000 steps/day).
* With mobile phone and e-mail
* Without intellectual deficits or difficulty to understand the language.

Exclusion Criteria

* Chronic disease: diabetes, high pressure, cardiac or respiratory disease, liver or kidney disease or mobility problems.
* Women with relative or absolute repose.
* Active women (\>5 days/week of moderate-vigorous physical activity at least \>30 min.; equivalent to \>7.000 steps/day).
* Insomnia at beginning of pregnancy or having drugs for sleep problems.
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Granada

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carmen Amezcua Prieto

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carmen Amezcua Prieto

Role: PRINCIPAL_INVESTIGATOR

Universidad de Granada

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Virgen de las Nieves

Granada, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carmen Amezcua Prieto

Role: CONTACT

+34 958241000 ext. 20287

References

Explore related publications, articles, or registry entries linked to this study.

Benito-Villena R, Cano-Ibanez N, Roman-Galvez RM, Martin-Pelaez S, Khan KS, Martinez-Galiano JM, Mozas-Moreno J, Amezcua-Prieto C. Gestational weight gain and daily life impact of pregnancy symptoms in healthy women: A multivariable analysis. Eur J Obstet Gynecol Reprod Biol. 2024 Dec;303:85-90. doi: 10.1016/j.ejogrb.2024.10.023. Epub 2024 Oct 16.

Reference Type DERIVED
PMID: 39432928 (View on PubMed)

Amezcua-Prieto C, Naveiro-Fuentes M, Arco-Jimenez N, Olmedo-Requena R, Barrios-Rodriguez R, Vico-Zuniga I, Manzanares Galan S, Mozas-Moreno J, Jimenez-Moleon JJ, Gallo-Vallejo JL. Walking in pregnancy and prevention of insomnia in third trimester using pedometers: study protocol of Walking_Preg project (WPP). A randomized controlled trial. BMC Pregnancy Childbirth. 2020 Sep 10;20(1):521. doi: 10.1186/s12884-020-03225-y.

Reference Type DERIVED
PMID: 32912184 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI-0350-2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Self-Management of Sleep Among Older Adults
NCT03837249 COMPLETED EARLY_PHASE1
Zolpidem or Exercise for Insomnia?
NCT03160404 COMPLETED EARLY_PHASE1
Circadian Rhythm Monitoring Study
NCT07336654 NOT_YET_RECRUITING NA